Pediatric Innovation Fund

Prize: up to $100,000 
Status: Closed

General Guidelines

Eligibility

Children’s National is seeking proposals from inventors who have medical product concepts for use with pediatric patients. Proposals should address a significant, yet unmet need within the pediatric population with a specific innovative “product” and plan for commercialization.

For the purpose of the Pediatric Innovation Fund, we define pediatric medical product as a medical instrument, apparatus, implant, in vitro reagent, methodology, drug, biologic agent or similar or related article that is used to maintain health or diagnose, prevent or treat disease or other conditions. The Fund administrators also encourage the development of healthcare software and mobile medical apps that improve pediatric health care and provide children, parents and health care professionals with valuable health information. In sum, all pediatric products (devices, drugs/biologics, diagnostic test, software, etc.) are eligible under this RFP.

The proposal should be directed towards development of a product, not research of a scientific concept. It should define the specific gap/need to be addressed, its quantitative significance (including market, etc.), the competitive landscape, how the proposed product will address the gap, project feasibility, the plan for regulatory approval and commercialization. For devices, issues such as prototyping, manufacturing, marketing, and regulatory clearance will beparamount and should be addressed explicitly. We enthusiastically welcome projects that are past the prototype phase. We are seeking funds to obtain additional product validation that is much required for product commercialization. 

The fund is designated for Children’s National employees or innovators from an external entity that collaborate with Children’s National. If the applicants are working with an external collaborator, the distribution of the external entity/subcontractor cannot exceed 40% of the total budget.